These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 8077931)
1. The establishment of cytomegalovirus latency in organs is not linked to local virus production during primary infection. Balthesen M; Dreher L; Lucin P; Reddehase MJ J Gen Virol; 1994 Sep; 75 ( Pt 9)():2329-36. PubMed ID: 8077931 [TBL] [Abstract][Full Text] [Related]
2. The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease. Reddehase MJ; Balthesen M; Rapp M; Jonjić S; Pavić I; Koszinowski UH J Exp Med; 1994 Jan; 179(1):185-93. PubMed ID: 8270864 [TBL] [Abstract][Full Text] [Related]
3. Preemptive CD8 T-cell immunotherapy of acute cytomegalovirus infection prevents lethal disease, limits the burden of latent viral genomes, and reduces the risk of virus recurrence. Steffens HP; Kurz S; Holtappels R; Reddehase MJ J Virol; 1998 Mar; 72(3):1797-804. PubMed ID: 9499030 [TBL] [Abstract][Full Text] [Related]
4. Lungs are a major organ site of cytomegalovirus latency and recurrence. Balthesen M; Messerle M; Reddehase MJ J Virol; 1993 Sep; 67(9):5360-6. PubMed ID: 8394453 [TBL] [Abstract][Full Text] [Related]
6. Murine model of interstitial cytomegalovirus pneumonia in syngeneic bone marrow transplantation: persistence of protective pulmonary CD8-T-cell infiltrates after clearance of acute infection. Podlech J; Holtappels R; Pahl-Seibert MF; Steffens HP; Reddehase MJ J Virol; 2000 Aug; 74(16):7496-507. PubMed ID: 10906203 [TBL] [Abstract][Full Text] [Related]
7. T-lymphocyte effects on murine cytomegalovirus pulmonary infection. Kadima-Nzuji M; Craighead JE Am J Pathol; 1990 Oct; 137(4):907-12. PubMed ID: 2171343 [TBL] [Abstract][Full Text] [Related]
8. Reconstitution of CD8 T cells is essential for the prevention of multiple-organ cytomegalovirus histopathology after bone marrow transplantation. Podlech J; Holtappels R; Wirtz N; Steffens HP; Reddehase MJ J Gen Virol; 1998 Sep; 79 ( Pt 9)():2099-104. PubMed ID: 9747717 [TBL] [Abstract][Full Text] [Related]
9. Successful treatment of murine cytomegalovirus disease does not prevent latent virus infection. Katzenstein DA; Crane RT; Jordan MC J Lab Clin Med; 1986 Aug; 108(2):155-60. PubMed ID: 3016127 [TBL] [Abstract][Full Text] [Related]
10. Nitric oxide increases the amount of murine cytomegalovirus-DNA in mice latently infected with the virus. Okada K; Tanaka K; Noda S; Okazaki M; Koga Y Arch Virol; 1999; 144(12):2273-90. PubMed ID: 10664384 [TBL] [Abstract][Full Text] [Related]
11. In vivo model for the acute, latent and reactivated phases of cytomegalovirus infection. Gönczöl E; Danczig E; Boldogh I; Tóth T; Váczi L Acta Microbiol Hung; 1985; 32(1):39-47. PubMed ID: 2994350 [TBL] [Abstract][Full Text] [Related]
12. Direct evidence using in situ polymerase chain reaction that the endothelial cell and T-lymphocyte harbor latent murine cytomegalovirus. Koffron AJ; Mueller KH; Kaufman DB; Stuart FP; Patterson B; Abecassis MI Scand J Infect Dis Suppl; 1995; 99():61-2. PubMed ID: 8668944 [TBL] [Abstract][Full Text] [Related]
13. Pediatric roots of cytomegalovirus recurrence and memory inflation in the elderly. Adler SP; Reddehase MJ Med Microbiol Immunol; 2019 Aug; 208(3-4):323-328. PubMed ID: 31062089 [TBL] [Abstract][Full Text] [Related]
14. Detection of mouse cytomegalovirus nucleic acid in latently infected mice by in vitro enzymatic amplification. Klotman ME; Henry SC; Greene RC; Brazy PC; Klotman PE; Hamilton JD J Infect Dis; 1990 Feb; 161(2):220-5. PubMed ID: 2153738 [TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of cytomegalovirus pneumonia in immunocompromised hosts. Riddell SR Semin Respir Infect; 1995 Dec; 10(4):199-208. PubMed ID: 8668847 [TBL] [Abstract][Full Text] [Related]
16. Evidence against a key role for transforming growth factor-beta1 in cytomegalovirus-induced bone marrow aplasia. Dobonici M; Podlech J; Steffens HP; Maiberger S; Reddehase MJ J Gen Virol; 1998 Apr; 79 ( Pt 4)():867-76. PubMed ID: 9568983 [TBL] [Abstract][Full Text] [Related]
17. Murine cytomegalovirus is present in both chronic active and latent states in persistently infected mice. Yuhasz SA; Dissette VB; Cook ML; Stevens JG Virology; 1994 Jul; 202(1):272-80. PubMed ID: 8009839 [TBL] [Abstract][Full Text] [Related]
18. Allogeneic cell stimulation enhances cytomegalovirus replication in the early period of primary infection in an experimental rat model. Tamura K; Oka T; Ohsawa K; Koji T; Watanabe Y; Katamine S; Sato H; Ayabe H J Heart Lung Transplant; 2003 Apr; 22(4):452-9. PubMed ID: 12681423 [TBL] [Abstract][Full Text] [Related]
19. Immunosuppression reactivates and disseminates latent murine cytomegalovirus. Jordan MC; Shanley JD; Stevens JG J Gen Virol; 1977 Nov; 37(2):419-23. PubMed ID: 200714 [TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus latency and latency-specific transcription in hematopoietic progenitors. Kondo K; Mocarski ES Scand J Infect Dis Suppl; 1995; 99():63-7. PubMed ID: 8668945 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]